Erratum: Virtual screening using ligand-based pharmacophores for inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) (DOI:10.1016/j.bmc.2010.02.008)

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 6, 2010, Pages 2347-2355

  Weidlich, Iwona E ^a   Dexheimer, Thomas S ^b   Marchand, Christophe ^b   Antony, Smitha ^b   Pommier, Yves ^b   Nicklaus, Marc C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Drug design; Human tyrosyl DNA phosphodiesterase; Inhibitors; Small molecule docking; Tdp1; Virtual screening

Indexed keywords

NSC 109131; NSC 120686; NSC 128609; NSC 88915; PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; BLOOD BRAIN BARRIER; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; COVALENT BOND; CRYSTAL STRUCTURE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG SCREENING; ENZYME ACTIVE SITE; ENZYME SUBSTRATE; ERRATUM; HYDROPHOBICITY; LIGAND BINDING; MOLECULAR DOCKING; NONHUMAN; NUCLEOTIDE BINDING SITE; PHARMACOPHORE; PROTEIN DOMAIN; STRUCTURE ACTIVITY RELATION; THREE DIMENSIONAL IMAGING; X RAY ANALYSIS;

EID: 77949273813     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.02.009     Document Type: Erratum

References (30)

1. Pouliot J.J., and Yao K.C. Science 286 (1999) 552-555
2. Pouliot J.J., and Robertson C.A. Genes Cells 6 (2001) 677-687
3. Vance J.R., and Wilson T.E. PNAS 99 (2002) 13669-13674
4. Dexheimer T.S., Antony S., Marchand C., and Pommier Y. Anti-Cancer Agents Med. Chem. 8 (2008) 381-389
5. Antony S., Marchand C., Stephen A.G., Thibaut L., Agama K.K., Fisher R.J., and Pommier Y. Nucleic Acids Res. 35 (2007) 4474-4484
6. Davies D.R., Interthal H., Champoux J.J., and Hol W.G.J. J. Med. Chem. 47 (2004) 829
7. Davies D.R., Interthal H., Champoux J.J., and Hol W.G.J. Structure 10 (2002) 237-248
8. Interthal H., Pouliot J.J., and Champoux J.J. PNAS 98 (2001) 12009-12014
9. Davies D.R., and Champoux J.J. J. Mol. Biol. 324 (2002) 917-932
10. Davies D.R., Interthal H., and Champoux. Chem. Biol. 10 (2003) 139-147
11. Coupez B., and Möbitz H. Chem. Modell.: Appl. Theor. 4 (2006) 1-22
12. Update on the publication status of these compounds can be obtained from Christophe Marchand at marchanc@mail.nih.gov.
13. The Enhanced NCI Database Browser, made available on the web server http://cactus.nci.nih.gov of the CADD Group, Lab. of Medicinal Chemistry, NCI, is an interface to the Open NCI Database, which is a collection of compounds submitted to DTP (Developmental Therapeutics Program), NCI, from a wide variety of academic and industrial labs around the world for screening against cancer and AIDS.
14. catalyst, Release 4.11, Accelrys Software, San Diego, 2005.
15. The ChemNavigator iResearch Library is a compilation of commercially available chemical compounds, in particular screening samples. http://www.chemnavigator.com/cnc/products/iRL.asp.
16. pipeline pilot, version 5.0, SciTegic, San Diego, CA, 2005.
17. This component filters out molecules that are likely to be poor candidates for high-throughput screening, including those containing non-organic atom types, reactive substructures, and those with a molecular weight >150.
18. Proudfoot J.R. BMCL 12 (2002) 1647-1650
19. qikprop, version 3.0, Schrödinger, LLC, New York, NY, 2007.
20. admet predictor, Version 2.3.0, Simulations Plus, Lancaster, CA, 2007.
21. Liao Z., Tribaut L., and Pommier Y. Mol. Pharmacol. 70 (2006) 366-372
22. glide, version 5.0, Schrödinger, LLC, New York, NY, 2008.
23. Chemical Computing Group's Molecular Operating Environment (moe), version 1008.10, 2008.
24. macromodel 9.6, Schrodinger, LLC, New York, NY, 2008.
25. Dexheimer T.S., Gediya L.K., Stephen A.G., Weidlich I., Antony S., Marchand C., Interhal H., Nicklaus M.C., Fisher R., Njar V.C., and Pommier Y. J. Med. Chem. 52 (2009) 7122-7131
26. Marchand C., Lea W.A., Jadhav A., Dexheimer T.S., Austin C.P., Inglese J., Pommier Y., and Simeonov A. Mol. Cancer Ther. 8 (2009) 240-248
27. http://dtp.nci.nih.gov/docs/CBC/cbc_index.html.
28. Rishton G.M. Drug Discovery Today 8 (2003) 86-96
29. Graves A.P. J. Mol. Biol. 377 (2008) 914-934
30. ligprep, Schrödinger, LLC, New York, NY, 2007.